APstem Therapeutics was founded in 2017 by scientists from Stanford University, to develop novel technologies and therapies using a new type of adult pluripotent stem cells that can expand rapidly and differentiate into cell lineages originated from three germ layers. Our mission is to develop novel stem cell technology targeting unmet medical needs.